Tumor Lesion Uptake of [ 177 Lu]Lu-DOTA-Rituximab in Skeletal and Splenic Disease in Diffuse Large B-Cell Lymphoma. Edamadaka Y, Parghane RV, Basu S. Clin Nucl Med 2025;50:e292-e293.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Edamadaka Y, Parghane RV, Basu S. Tumor Lesion Uptake of [ 177 Lu]Lu-DOTA-Rituximab in Skeletal and Splenic Disease in Diffuse Large B-Cell Lymphoma. Clin Nucl Med 2025;50:e292-e293.
PMID: 39876085